We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

January 1, 2018

Plaintiff(s) v. Defendant(s)

Track this case

Case Number:




Nature of Suit:

Other Statutory Actions

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. February 7, 2018

    FDA Approves Gilead's HIV Med; Rival Claims Infringement

    Hours after the U.S. Food and Drug Administration approved Gilead Sciences Inc.’s new HIV medication Biktarvy, rival ViiV Healthcare Co. filed a patent infringement lawsuit in Delaware federal court Wednesday accusing the biotech company of copying its Tivicay drug, which in 2016 hit $1.4 billion in sales.

5 other articles on this case. View all »


To view the parties, register now.